A Low‐Cost, Microcontroller‐Based Gas Delivery System for Respiratory Stimuli in MRI Studies
Magnetic Resonance in Medicine · 2026
DOI: 10.1002/mrm.70543 ↗At a glance
Journal article in Magnetic Resonance in Medicine, 2026. Written by Nicholas P Blockley and 5 co-authors. Institution: David Greenfield Human Physiology Unit, School of Life Sciences, University of Nottingham, Nottingham, UK. Major MEDLINE topics: Magnetic Resonance Imaging, Oxygen, Carbon Dioxide, Hypercapnia. 19 references. Funded by: Nottingham BBSRC Doctoral Training Partnership, EPSRC, NIHR Nottingham Biomedical Research Centre.
Abstract (original language)
Purpose
The design and validation of a low‐cost, microcontroller‐based gas delivery system that automates fixed inspired respiratory stimuli for MRI experiments.
Methods
The system uses three solenoid valves controlled by an Arduino‐based circuit to switch between premixed medical gases according to predefined timings. By using the MRI scanner external timing signal, gas delivery can be synchronized with image acquisition. The system was constructed using commercial components, with a material cost ∼£650 GBP (∼$880 USD). The system was integrated with a single‐use breathing circuit and evaluated using hypercapnic and hyperoxic stimuli. End‐tidal oxygen (O 2 ) and carbon dioxide (CO 2 ) were measured using a respiratory gas analyzer and physiological responses were assessed using BOLD MRI at 3 T.
Results
The system delivered reliable, repeatable gas transitions during MRI‐triggered protocols. During hypercapnia (elevated carbon dioxide level, 5% CO 2 ) ( n = 15), the mean increase in end‐tidal CO 2 was 8.7 ± 1.8 mmHg from a baseline of 32.2 ± 3.1 mmHg, producing a mean gray matter BOLD signal increase of 3.2% ± 1.7%. During hyperoxia (elevated oxygen level, 60.5% O 2 ) ( n = 15), the mean increase in end‐tidal O 2 was 292.3 ± 59.0 mmHg from a baseline of 114.5 ± 10.7 mmHg, with an associated BOLD signal change of 1.2% ± 1.7%. Across both protocols, respiratory and BOLD responses were consistent across participants.
Conclusion
This microcontroller‐based system provides an inexpensive and reliable method for administering fixed inspired respiratory stimuli with automated MRI synchronization. It offers an intermediate option between manual systems and commercial gas blenders, making it well suited for technical and methodological studies in cerebrovascular reactivity, hyperoxia‐BOLD, and related applications.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- David Greenfield Human Physiology Unit, School of Life Sciences, University of Nottingham, Nottingham, UK.
- Radiology Department, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.
- Institute of Biomedical Engineering, University of Oxford, Oxford, UK.
- Oxford Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, Oxford, UK.
ORCID profiles: Nicholas P Blockley
Funding
- Nottingham BBSRC Doctoral Training Partnership
- EPSRC
- NIHR Nottingham Biomedical Research Centre
- NIHR Oxford Health Biomedical Research Centre
- UKRI
- Wellcome Trust
- Engineering and Physical Sciences Research Council
- UK Research and Innovation
Cite
APA
Blockley, N. P., Alzaidi, A. A., Milbourn, C. C., Bulte, D. P., Rudgewick-Brown, A., & Rieger, S. W. (2026). A Low‐Cost, Microcontroller‐Based Gas Delivery System for Respiratory Stimuli in MRI Studies. Magnetic Resonance in Medicine. https://doi.org/10.1002/mrm.70543
Vancouver
Blockley NP, Alzaidi AA, Milbourn CC, Bulte DP, Rudgewick-Brown A, Rieger SW. A Low‐Cost, Microcontroller‐Based Gas Delivery System for Respiratory Stimuli in MRI Studies. Magnetic Resonance in Medicine. 2026. doi:10.1002/mrm.70543
BibTeX
@article{Blockley2026,
author = {Blockley, Nicholas P and Alzaidi, Ahlam A and Milbourn, Colette C and Bulte, Daniel P and Rudgewick-Brown, Andrew and Rieger, Sebastian W},
title = {A Low‐Cost, Microcontroller‐Based Gas Delivery System for Respiratory Stimuli in MRI Studies},
journal = {Magnetic Resonance in Medicine},
year = {2026},
doi = {10.1002/mrm.70543}
}
EUVIMED